Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints (those between the spine and hipbone). Less commonly, AS can affect other joints such ... Syracuse.com: Hearing loss, ankylosing spondylitis & things you might not know (Enable: The Disability Podcast) The Disability Podcast,” co-hosts Geoff “DeafGeoff” Herbert and Kurt Hower answer questions about their own different abilities, including hearing loss, ankylosing spondylitis and OCD (obsessive ...
Hearing loss, ankylosing spondylitis & things you might not know (Enable: The Disability Podcast) Morning back pain can signal more than just back muscle stiffness. A new review suggests that whole body cryotherapy could be the answer to address ankylosing spondylitis. Ankylosing spondylitis (AS) is a chronic inflammatory condition that mainly affects the spine. The condition usually requires medical treatments, but some home remedies can also reduce symptoms.
ankylosing spondylitis cause, AS is ... A debilitating autoimmune condition silently attacks the spine and surrounding joints, causing inflammation that gradually transforms flexible vertebrae into rigid, fused bone. Ankylosing spondylitis ... Medscape: CV Disease, Drug Abuse Big Contributors to Mortality in Ankylosing Spondylitis Drug use disorder increased the likelihood of in-hospital mortality more than 10-fold in patients with ankylosing spondylitis (AS), compared with patients who did not die while hospitalized. For decades, ankylosing spondylitis was considered a man’s disease, but new research reveals something shocking: ankylosing spondylitis hits women differently and nearly as frequently as men, yet ...
ankylosing spondylitis cause, Healio: Median survival of first-line TNF inhibitor in ankylosing spondylitis nearly 11 years Median survival of first-line TNF inhibitor in ankylosing spondylitis nearly 11 years Ivarmacitinib, a highly selective Janus kinase 1 (JAK1) inhibitor, tamed ankylosing spondylitis with sustained efficacy through 24 weeks in a phase 2/3 trial. A phase 2/3 trial in China evaluated the ... Tumor necrosis factor inhibitors may offer mental health benefits in the management of patients with ankylosing spondylitis.
